Theranos In ‘Pause Period’ As It Looks For FDA Approval
The blood test maker is facing scrutiny over its testing methods. Elsewhere, lower earnings for insurer Assurant, hospital operator Community Health Systems and biodrug firm Biogen lead to market palpitations.